What is the current size of the whole body imaging market?

The market valuation of the whole body imaging is USD 34.46 billion in 2027.

How is the whole body imaging industry size expected to evolve during the forecast period?

Whole Body Imaging Market size was over USD 32.9 billion in 2026 and is likely to grow at a 5.64% CAGR between 2027 and 2036, exceeding USD 56.95 billion by 2036.

How is the rising burden of chronic diseases driving demand for whole body imaging solutions?

Growing prevalence of cancer, cardiovascular, and metabolic diseases is increasing demand for comprehensive imaging that supports staging, surveillance, and treatment planning. Whole body imaging enables faster, system-wide assessment of complex patients.

How is AI integration transforming efficiency and adoption in whole body imaging systems?

AI-enabled CT and MRI systems improve workflow efficiency through faster reconstruction, automated detection, and optimized protocols. This reduces radiology bottlenecks and supports broader adoption of full-body imaging in high-volume clinical environments.

Why do hospitals dominate the whole body imaging market?

Hospitals held 48.65% share in 2026 due to high patient volumes, integrated emergency and specialty care workflows, and ability to manage complex imaging cases requiring multidisciplinary coordination.

Why is CT the fastest-growing imaging modality?

Computed Tomography (CT) is the fastest-growing modality due to rapid scan times, improved workflow efficiency, and suitability for high-volume diagnostic environments requiring quick clinical decision-making.

Why is North America the leading region in the whole body imaging market?

North America holds 36.46% share due to advanced imaging infrastructure, widespread clinical use across oncology and neurology, and strong capacity for integrating high-value diagnostic systems into routine care.

What is driving growth in Asia Pacific’s whole body imaging market?

Asia Pacific is expanding at a 6.78% CAGR, driven by expanding diagnostic infrastructure, rising access to advanced imaging systems, and increasing demand for early and comprehensive disease detection.

Who are the leading players in the whole body imaging landscape?

Key companies in the whole body imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Mediso Ltd. (Hungary), Hologic, Inc. (United States).